EDGAR Filing Documents for 0001144204-17-044192

Form F-3 - Registration statement by foreign private issuers:

SEC Accession No. 0001144204-17-044192

Filing Date

2017-08-18

Accepted

2017-08-18 16:32:39

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	F-3	v473550_f3.htm	F-3	399818
2	EXHIBIT 23.1	v473550_ex23-1.htm	EX-23.1	5242
3	EXHIBIT 23.2	v473550_ex23-2.htm	EX-23.2	4619
	Complete submission text file	0001144204-17-044192.txt		410842

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: F-3 | Act: 33 | File No.: 333-220052 | Film No.: 171041409
SIC: 2834 Pharmaceutical Preparations